Literature DB >> 33804526

May-Thurner Syndrome Is Aggravated by Pregnancy.

Kuntharee Traisrisilp1, Manatsawee Manopunya1, Tanop Srisuwan1, Wisit Chankhunaphas1, Theera Tongsong1.   

Abstract

This study aims to emphasize that asymptomatic patients with undiagnosed and asymptomatic May-Thurner syndrome (MTS) may firstly develop severe compression during pregnancy. A 40-year-old woman, G1P0, at 22 weeks of twin gestation presented with left lower extremity edema and pain. One twin was structurally normal while the other had bilateral renal agenesis with oligohydramnios. Magnetic resonance venography (MRV) revealed severe compression of the left iliac vein by the right iliac artery without evidence of deep vein thrombosis (DVT). Conservative treatment with anticoagulant prophylaxis was instituted throughout the rest of pregnancy and postpartum period. She was also complicated with severe pre-eclampsia, a cesarean section was performed due to a prolapsed cord at 27 weeks of gestation, and she gave birth to a surviving baby weighing 1100 g. In conclusion, this case report provides evidence that pregnancy can disclose a subtle May-Thurner anatomy to be symptomatic without DVT. Successful pregnancy outcomes could be achieved with conservative treatment and anticoagulant prophylaxis.

Entities:  

Keywords:  May-Thurner syndrome; deep vein thrombosis; pregnancy

Year:  2021        PMID: 33804526      PMCID: PMC7999580          DOI: 10.3390/medicina57030222

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  10 in total

1.  The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins.

Authors:  R MAY; J THURNER
Journal:  Angiology       Date:  1957-10       Impact factor: 3.619

2.  May-Thurner Syndrome: A Cause of Acute Left Iliac Vein Obstruction in Early Postpartum Period: A Case Report.

Authors:  Hina Inam; Fareed Ahmed Shaikh; Nadeem Ahmed Siddiqui
Journal:  J Pak Med Assoc       Date:  2019-07       Impact factor: 0.781

3.  Anticoagulant Therapy in a Pregnant Woman with May-Thurner Syndrome.

Authors:  Masaki Goto; Shin-Ichiro Miura; Tomohiko Yamamoto; Yusuke Fukuda; Takashi Kuwano; Ibuki Kimura; Ayako Sanui; Shingo Miyamoto; Keijiro Saku
Journal:  Intern Med       Date:  2016-01-01       Impact factor: 1.271

4.  May-Thurner syndrome resulting in acute iliofemoral deep vein thrombosis during the second trimester of pregnancy.

Authors:  Yoshiyuki Nakajima; Naoki Masaoka; Yoko Tsuzuki; Masako Morooka; Masato Sakai
Journal:  J Obstet Gynaecol Res       Date:  2012-04-30       Impact factor: 1.730

5.  Computed tomography findings in 10 cases of iliac vein compression (May-Thurner) syndrome.

Authors:  Levent Oguzkurt; Fahri Tercan; M Ali Pourbagher; Osman Kizilkilic; Riza Turkoz; Fatih Boyvat
Journal:  Eur J Radiol       Date:  2004-12-10       Impact factor: 3.528

6.  Cerebral infarction in conjunction with patent foramen ovale and May-Thurner syndrome.

Authors:  D M Greer; F S Buonanno
Journal:  J Neuroimaging       Date:  2001-10       Impact factor: 2.486

7.  May-Thurner syndrome - Are we aware enough?

Authors:  Katalin Mako; Attila Puskas
Journal:  Vasa       Date:  2019-02-20       Impact factor: 1.961

8.  May-Thurner syndrome complicating pregnancy: a report of four cases.

Authors:  Joseph R Wax; Michael G Pinette; Daniel Rausch; Angelina Cartin
Journal:  J Reprod Med       Date:  2014 May-Jun       Impact factor: 0.142

9.  Diagnosis and management of iliac vein thrombosis in pregnancy resulting from May-Thurner Syndrome.

Authors:  C C DeStephano; E F Werner; B P Holly; M L Lessne
Journal:  J Perinatol       Date:  2014-07       Impact factor: 2.521

10.  Phlegmasia Cerulea Dolens and May-Thurner Syndrome in the first trimester of Pregnancy.

Authors:  Aliya B Ladha; Rizwana Fareeduddin
Journal:  AJP Rep       Date:  2015-11-16
  10 in total
  1 in total

1.  Thrombotic Disorders and Antithrombotic Treatments Special Issue.

Authors:  Pierpaolo Di Micco
Journal:  Medicina (Kaunas)       Date:  2022-02-02       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.